BioStock published an article on 20 May 2021 about Cyxone, which can be read in full below. Recently, Malmö-based company Cyxone, announced the next development steps for its drug candidate T20K for the treatment of multiple sclerosis. A process...
Read MoreBioStock published an article on 18 May 2021 about Cyxone, which can be read in full below. Biotech company Cyxone is in the process of preparing drug candidate Rabeximod for the next clinical stage. Recently, the company announced a...
Read MoreRead the article with CEO Tara Heitner and COO Malin Berthold telling the story how Cyxone initiated the Covid-19 trial. Read the article here.
Read MoreBioStock published an article on 24 February 2021 about Cyxone, which can be read in full below. Biotech company Cyxone recently published its fourth quarter result, a period with great focus in the advancement of the project with the...
Read MoreBioStock published an article on 22 January 2021 about Cyxone, which can be read in full below. Last week, the biotech company Cyxone announced that the first patient has been screened in the phase II trial with their candidate...
Read MoreBioStock published an article on 14 December 2020 about Cyxone, which can be read in full below. Activity is high in Cyxone. The biotechnology company recently received approval to start a phase II study in Poland with Rabeximod in...
Read MoreBioStock published an article on 13 November 2020 about Cyxone, which can be read in full below. In a short period of time, biotech company Cyxone has secured some 40 MSEK to fund the phase II study of Rabeximod...
Read MoreBioStock published an article on 10 November 2020 about Cyxone, which can be read in full below. Recently, biotech company Cyxone announced positive results from completed toxicological studies of the drug candidate Rabeximod for treatment of rheumatoid arthritis. The...
Read MoreStartus Insights ranks Cyxone as one of five top specialty pharma startups impacting the industry. Link to Startus Insights ranking
Read MoreBioStock published an article on 4 July 2019 about autoimmune diseases, which can be read in full below. Therapies for autoimmune diseases are available but do not work for all patients, and when they do, side effects can be...
Read More